Business Description
Naturewise Biotech & Medicals Corp
NAICS : 325411
SIC : 2833
ISIN : TW0004732003
Description
Naturewise Biotech & Medicals Corp is a Taiwan-based drug development company that focuses on botanical drug and small molecule therapies. Its products include NBM-BMX Oral Softgel Capsule, Lipocol Forte Capsule, and PPLs Taiwan Green Propolis.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 44.49 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.52 | |||||
| Interest Coverage | 65.98 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 12.89 | |||||
| Beneish M-Score | -3.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -19.8 | |||||
| 3-Year EBITDA Growth Rate | -34.4 | |||||
| 3-Year EPS without NRI Growth Rate | -46.7 | |||||
| 3-Year FCF Growth Rate | 3.9 | |||||
| 3-Year Book Growth Rate | 1.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.31 | |||||
| 9-Day RSI | 64.32 | |||||
| 14-Day RSI | 60.22 | |||||
| 6-1 Month Momentum % | 6.87 | |||||
| 12-1 Month Momentum % | -11.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.55 | |||||
| Quick Ratio | 10.03 | |||||
| Cash Ratio | 8.75 | |||||
| Days Inventory | 318.01 | |||||
| Days Sales Outstanding | 62.63 | |||||
| Days Payable | 45.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.93 | |||||
| Dividend Payout Ratio | 2.5 | |||||
| Forward Dividend Yield % | 1.93 | |||||
| 5-Year Yield-on-Cost % | 1.93 | |||||
| Shareholder Yield % | 1.8 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.56 | |||||
| Operating Margin % | 2.14 | |||||
| Net Margin % | 6.32 | |||||
| FCF Margin % | 38.45 | |||||
| ROE % | 1.6 | |||||
| ROA % | 1.46 | |||||
| ROIC % | 2.21 | |||||
| ROC (Joel Greenblatt) % | 16.66 | |||||
| ROCE % | 1.55 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 131.75 | |||||
| PE Ratio without NRI | 131.75 | |||||
| Price-to-Owner-Earnings | 21.22 | |||||
| PS Ratio | 8.21 | |||||
| PB Ratio | 2.05 | |||||
| Price-to-Tangible-Book | 2.18 | |||||
| Price-to-Free-Cash-Flow | 21.35 | |||||
| Price-to-Operating-Cash-Flow | 21.14 | |||||
| EV-to-EBIT | 83.62 | |||||
| EV-to-EBITDA | 40.91 | |||||
| EV-to-Revenue | 5.21 | |||||
| EV-to-FCF | 12.71 | |||||
| Price-to-Projected-FCF | 1.99 | |||||
| Price-to-Median-PS-Value | 1.13 | |||||
| Price-to-Graham-Number | 3.57 | |||||
| Price-to-Net-Current-Asset-Value | 2.31 | |||||
| Price-to-Net-Cash | 3.16 | |||||
| Earnings Yield (Greenblatt) % | 1.19 | |||||
| FCF Yield % | 4.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Naturewise Biotech & Medicals Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 160.142 | ||
| EPS (TTM) (NT$) | 0.2 | ||
| Beta | 1.51 | ||
| Volatility % | 32.41 | ||
| 14-Day RSI | 60.22 | ||
| 14-Day ATR (NT$) | 0.92243 | ||
| 20-Day SMA (NT$) | 25.1975 | ||
| 12-1 Month Momentum % | -11.23 | ||
| 52-Week Range (NT$) | 22.05 - 36.75 | ||
| Shares Outstanding (Mil) | 49.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Naturewise Biotech & Medicals Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Naturewise Biotech & Medicals Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Naturewise Biotech & Medicals Corp Frequently Asked Questions
What is Naturewise Biotech & Medicals Corp(ROCO:4732)'s stock price today?
The current price of ROCO:4732 is NT$26.35. The 52 week high of ROCO:4732 is NT$36.75 and 52 week low is NT$22.05.
When is next earnings date of Naturewise Biotech & Medicals Corp(ROCO:4732)?
The next earnings date of Naturewise Biotech & Medicals Corp(ROCO:4732) is .
Does Naturewise Biotech & Medicals Corp(ROCO:4732) pay dividends? If so, how much?
The Dividend Yield %  of Naturewise Biotech & Medicals Corp(ROCO:4732) is 1.93% (As of Today), Highest Dividend Payout Ratio of Naturewise Biotech & Medicals Corp(ROCO:4732) was 2.5. The lowest was 0.16. And the median was 0.49. The  Forward Dividend Yield % of Naturewise Biotech & Medicals Corp(ROCO:4732) is 1.93%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers